2022. In Silico Designing, ADMET Screening, MM/GBSA Binding Free Energy of Some Novel 8-Amino Substituted Apigenin Derivatives as DPP-IV Inhibitors Targeting Type-II Diabetes Mellitus. Journal of Pharmaceutical Negative Results. 13, (Dec. 2022), 2719–2729. DOI:https://doi.org/10.47750/pnr.2022.13.S05.418.